Long-Term Testosterone Therapy Does Not Increase the Risk of Prostate Cancer
Article Title: Long-term testosterone therapy does not increase the risk of prostate cancer
Author: Elsevier Health Sciences
Date of Publication: November 25, 2014
“Testosterone (T) therapy is routinely used in men with hypogonadism, a condition in which diminished function of the gonads occurs. Although there is no evidence that T therapy increases the risk of prostate cancer (PCa), there are still concerns and a paucity of long-term data. In a new study in The Journal of Urology®, investigators examined three parallel, prospective, ongoing, cumulative registry studies of over 1,000 men. Their analysis showed that long-term T therapy in hypogonadal men is safe and does not increase the risk of PCa.